GSK-5628

N/A

Report date: 2025/01/26 17:28:45
NME

Base Information

Drug NameGSK-5628
Drug Alias NameIDO-1 checkpoint inhibitor (GlaxoSmithKline)IDO checkpoint inhibitor (GlaxoSmithKline)indoleamine-2,3-dioxygenase-1 inhibitor (GlaxoSmithKline)GSK-5628
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A